BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34321172)

  • 1. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
    Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
    Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
    Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
    Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.
    Zhang X; Cao D; Liu J; Zhang Q; Liu M
    Medicine (Baltimore); 2020 Jul; 99(30):e21404. PubMed ID: 32791754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
    Li WF; Hu CC; Ding YL; Yuan B
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Sun XH; Zhang S; Yang Z; Chen ZL; Yue SJ; Zhang S; Tang YP
    Chin J Integr Med; 2022 Jul; 28(7):650-660. PubMed ID: 35776293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.
    Hong L; He M; Li S; Zhao J
    Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.
    Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH
    J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule.
    Shen X; Yin F
    Biomed Pharmacother; 2021 Oct; 142():111998. PubMed ID: 34385103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials.
    Liang SB; Fang M; Liang CH; Lan HD; Shen C; Yan LJ; Hu XY; Han M; Robinson N; Liu JP
    Complement Ther Med; 2021 Aug; 60():102744. PubMed ID: 34091029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
    Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
    Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
    Xiao M; Tian J; Zhou Y; Xu X; Min X; Lv Y; Peng M; Zhang Y; Yan D; Lang S; Zhang Q; Fan A; Ke J; Li X; Liu B; Jiang M; Liu Q; Zhu J; Yang L; Zhu Z; Zeng K; Li C; Zheng Y; Wu H; Lin J; Lian F; Li X; Tong X
    Pharmacol Res; 2020 Nov; 161():105126. PubMed ID: 32781283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial.
    Zhan YQ; Chen RF; Zheng QS; Li XW; Liu YN; Mootsikapun P; Chayakulkeeree M; Arttawejkul P; Lan TTN; Liu GG; Lu HZ; Liu QQ; Zhong NS; Yang ZF; Zheng JP
    J Thorac Dis; 2023 May; 15(5):2859-2872. PubMed ID: 37324081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study.
    Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y
    Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese medicine Lianhua Qingwen for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
    Li S; Zhang J; Li F; Mao A; Li Y; Zhao C; Hu X; Li F; Wang W
    Medicine (Baltimore); 2021 Jan; 100(2):e24204. PubMed ID: 33466197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
    Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
    Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
    Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C
    Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
    Zeng M; Li L; Wu Z
    PLoS One; 2020; 15(9):e0238828. PubMed ID: 32915877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs.
    Chen Y; Zhang C; Wang N; Feng Y
    Chin J Nat Med; 2023 May; 21(5):383-400. PubMed ID: 37245876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.
    Wang Z; Yang L
    J Ethnopharmacol; 2021 Apr; 270():113869. PubMed ID: 33485973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis.
    Liu N; Zhang T; Ma L; Wang H; Cao Y; Yang Y; Pei H; Li H
    Medicine (Baltimore); 2020 Aug; 99(33):e21614. PubMed ID: 32872017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.